Cost-effectiveness analysis of the Lyme disease vaccine (Q43658392)

25 November 2017

title

Cost-effectiveness analysis of the Lyme disease vaccine (English)

1 reference

25 November 2017

0 references

Elizabeth C Hsia

1

1 reference

25 November 2017

James B Chung

series ordinal

2

1 reference

25 November 2017

J Sanford Schwartz

series ordinal

3

1 reference

25 November 2017

Daniel A Albert

series ordinal

4

1 reference

25 November 2017

publication date

1 June 2002

1 reference

25 November 2017

published in

Arthritis & Rheumatology

1 reference

25 November 2017

volume

46

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

1651-1660

1 reference

Vaccination as a modality to prevent Lyme disease. A status report

25 November 2017

cites work

1 reference

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

21 January 2018

1 reference

21 January 2018

1 reference

A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium

21 January 2018

1 reference

A cost-of-illness study of Lyme disease in the United States.

21 January 2018

1 reference

The Lyme disease vaccine: conception, development, and implementation

21 January 2018

1 reference

Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America

21 January 2018

1 reference

Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease. A cost-effectiveness analysis

21 January 2018

1 reference

Rapid emergence of a focal epidemic of Lyme disease in coastal Massachusetts

21 January 2018

1 reference

Lyme disease in outdoor workers: risk factors, preventive measures, and tick removal methods.

21 January 2018

1 reference

Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease

21 January 2018

1 reference

Long-term Outcomes of Persons With Lyme Disease

21 January 2018

1 reference

Predisposing factors for individuals' Lyme disease prevention practices: Connecticut, Maine, and Montana.

21 January 2018

1 reference

The geographic spread and temporal increase of the Lyme disease epidemic

21 January 2018

1 reference

Estimation of the incidence of Lyme disease.

21 January 2018

1 reference

Prevention of Lyme disease: a review of the evidence

21 January 2018

1 reference

Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite

21 January 2018

1 reference

The cost-effectiveness of vaccination against Lyme disease.

21 January 2018

1 reference

The cost effectiveness of vaccinating against Lyme disease

21 January 2018

1 reference

Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur

21 January 2018

1 reference

Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis

21 January 2018

1 reference

Anxiety and persistence of Lyme disease

21 January 2018

1 reference

The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study.

21 January 2018

1 reference

Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Lyme disease vaccines

1 reference

Prevention of Lyme disease after tick bites. A cost-effectiveness analysis

21 January 2018

1 reference

Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis

21 January 2018

1 reference

Occupational risk of Lyme disease in endemic areas of New York State

21 January 2018

1 reference

The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

The public health impact of Lyme disease in Maryland

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.10270

1 reference

25 November 2017

1 reference